{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:21:44Z","timestamp":1788873704105,"version":"build-2803163510"},"reference-count":92,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:p>Vitiligo is a common acquired depigmenting disorder characterized by the development of white macules and patches due to the loss of melanocytes. Patients with vitiligo can be stigmatized by society, making the disease a source of psychological stress that can considerably affect quality of life. The goal of vitiligo treatment is to obtain skin repigmentation in the majority of cases, and less commonly to depigment the remaining normal skin. There is no consistent, long-term, durable therapy for vitiligo for all patients, highlighting the unmet need for new safe and effective therapies to control this disease. Recently, JAK inhibitors have been explored as a promising novel treatment option in vitiligo. The JAK and signal transducers and activators of transcription (STAT) pathway is an attractive therapeutic target because IFN-\u03b3\u2013dependent cytokines produced through this pathway have been implicated in the pathogenesis of disease. This literature review describes vitiligo pathophysiology, explains the usefulness of the JAK inhibitors for treatment, and summarizes published case reports, case series, and open-label studies. Research outlined here shows JAK inhibitors in patients with vitiligo have a favorable safety profile and effectively produce repigmentation of lesions, especially with concomitant ultraviolet exposure. Additional studies are required to confirm efficacy, establish safety, and investigate durability of repigmentation.<\/jats:p>","DOI":"10.1177\/1203475419833609","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T01:44:50Z","timestamp":1553305490000},"page":"298-306","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":48,"title":["The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the Literature"],"prefix":"10.1177","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3416-6765","authenticated-orcid":false,"given":"Nicole","family":"Relke","sequence":"first","affiliation":[{"name":"Queen\u2019s University, Kingston, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8926-0113","authenticated-orcid":false,"given":"Melinda","family":"Gooderham","sequence":"additional","affiliation":[{"name":"Queen\u2019s University, Kingston, ON, Canada"},{"name":"SKiN Centre for Dermatology, Peterborough, ON, Canada"},{"name":"Probity Medical Research, Waterloo, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,3,22]]},"reference":[{"key":"bibr1-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0749.2003.00032.x"},{"key":"bibr2-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2012.00997.x"},{"key":"bibr3-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8622-7"},{"key":"bibr4-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.07.010"},{"key":"bibr5-1203475419833609","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.32708"},{"key":"bibr6-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02059.x"},{"key":"bibr7-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-1-58"},{"key":"bibr8-1203475419833609","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.39745"},{"key":"bibr9-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1978.01640210075025"},{"key":"bibr10-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09077.x"},{"key":"bibr11-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2005.01369.x"},{"key":"bibr12-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13198"},{"key":"bibr13-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-4-8"},{"key":"bibr14-1203475419833609","doi-asserted-by":"publisher","DOI":"10.17354\/ijss\/2017\/273"},{"key":"bibr15-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.2006.00355.x"},{"key":"bibr16-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90718-5"},{"key":"bibr17-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0749.2003.00070.x"},{"key":"bibr18-1203475419833609","first-page":"704","volume":"5","author":"Gauthier Y.","year":"1995","journal-title":"Eur J Dermatol"},{"issue":"2","key":"bibr19-1203475419833609","first-page":"131","volume":"70","author":"Gupta L","year":"2004","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"bibr20-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022443809606"},{"key":"bibr21-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.02.004"},{"key":"bibr22-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1985.tb02057.x"},{"key":"bibr23-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000343"},{"key":"bibr24-1203475419833609","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/938257"},{"key":"bibr25-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1159\/000081479"},{"key":"bibr26-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11198.x"},{"key":"bibr27-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60763-7"},{"key":"bibr28-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.1643"},{"key":"bibr29-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.321"},{"key":"bibr30-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb08486.x"},{"key":"bibr31-1203475419833609","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200102030-00006"},{"key":"bibr32-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.1993.tb00023.x"},{"key":"bibr33-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2007.06280.x"},{"key":"bibr34-1203475419833609","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565040-00002"},{"key":"bibr35-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.5.581"},{"key":"bibr36-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.12.031"},{"key":"bibr37-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0298-5"},{"key":"bibr38-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.5.578"},{"key":"bibr39-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06128.x"},{"key":"bibr40-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890480045006"},{"key":"bibr41-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70021-7"},{"key":"bibr42-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08776.x"},{"key":"bibr43-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04520.x"},{"key":"bibr44-1203475419833609","first-page":"191","volume":"66","author":"Harrist TJ","year":"1984","journal-title":"Natl Cancer Inst Monogr"},{"issue":"4","key":"bibr45-1203475419833609","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/0001555572305306","volume":"72","author":"Wildfang IL","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"bibr46-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1995.01690180114025"},{"key":"bibr47-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.113475"},{"key":"bibr48-1203475419833609","doi-asserted-by":"publisher","DOI":"10.3329\/bmj.v40i3.18675"},{"key":"bibr49-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00623.x"},{"key":"bibr50-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2012.12.003"},{"key":"bibr51-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0153-5"},{"key":"bibr52-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-11-7"},{"key":"bibr53-1203475419833609","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.87116"},{"key":"bibr54-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1971.04000240016002"},{"key":"bibr55-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12532"},{"key":"bibr56-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003263.pub5"},{"key":"bibr57-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007811"},{"key":"bibr58-1203475419833609","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.90946"},{"key":"bibr59-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13642"},{"key":"bibr60-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2004.30313.x"},{"key":"bibr61-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12762"},{"key":"bibr62-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2016.11.010"},{"issue":"2","key":"bibr63-1203475419833609","first-page":"93","volume":"65","author":"Savant S","year":"1999","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"bibr64-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum2015167"},{"key":"bibr65-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.201"},{"key":"bibr66-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.354"},{"key":"bibr67-1203475419833609","unstructured":"Maynard J. FDA briefing document: Baricitinib Janus kinase (JAK) inhibitor for RA. FDA Arthritis Advisory Committee meeting brief. NDA 207924: Baricitinib for RA. Eli Lilly and Company. April 23, 2018."},{"key":"bibr68-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210094"},{"key":"bibr69-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1002\/art.39953"},{"key":"bibr70-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507247"},{"key":"bibr71-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1277179"},{"key":"bibr72-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.12.005"},{"key":"bibr73-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-14-298"},{"key":"bibr74-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0880-2"},{"key":"bibr75-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0651-5"},{"key":"bibr76-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0622-2"},{"key":"bibr77-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.1520"},{"key":"bibr78-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13290"},{"key":"bibr79-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1339013"},{"key":"bibr80-1203475419833609","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2018.042"},{"key":"bibr81-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.05.043"},{"key":"bibr82-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5778"},{"key":"bibr83-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.09.073"},{"key":"bibr84-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.02.049"},{"key":"bibr85-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.023"},{"key":"bibr86-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3645"},{"key":"bibr87-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12264"},{"key":"bibr88-1203475419833609","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13432"},{"key":"bibr89-1203475419833609","unstructured":"A study of ATI-50002 topical solution for the treatment of vitiligo. 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03468855. Accessed August 29, 2018."},{"key":"bibr90-1203475419833609","unstructured":"A study of INCB018424 phosphate cream in subjects with vitiligo. 2017. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03099304. Accessed August 29, 2018."},{"key":"bibr91-1203475419833609","unstructured":"Topical ruxolitinib for the treatment of vitiligo. 2016. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02809976. Accessed August 29, 2018."},{"key":"bibr92-1203475419833609","unstructured":"A phase 2b study to evaluate the efficacy and safety profile of PF-06651600 and PF-06700841 in active non-segmental vitiligo subjects. 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03715829. Accessed January 5, 2019."}],"container-title":["Journal of Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1203475419833609","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1203475419833609","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1203475419833609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:54:15Z","timestamp":1777391655000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1203475419833609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1177\/1203475419833609"],"URL":"https:\/\/doi.org\/10.1177\/1203475419833609","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,22]]}}}